Child Kidney Dis.  2025 Feb;29(1):19-23. 10.3339/ckd.25.002.

How to treat recurrent focal segmental glomerulosclerosis after kidney transplantation in children

• Park PG

• KMID: 2565477
• DOI: http://doi.org/10.3339/ckd.25.002

Abstract

Focal segmental glomerulosclerosis (FSGS), a significant cause of kidney failure in children, is a common pathological diagnosis in cases of idiopathic nephrotic syndrome, especially steroid-resistant ones. FSGS has the potential to recur after kidney transplantation, often leading to graft loss. However, not all children with FSGS experience recurrence posttransplantation, such as those with genetic or secondary forms, which have minimal risk. Moreover, advancements in management, including intensive plasmapheresis and immunosuppressive therapies like rituximab, have increased remission rates in cases of recurrence. Identifying patients at high risk of recurrence, such as those with an initial treatment response or previous failed transplantation, is crucial. These children require close monitoring of proteinuria and prompt, intensive treatment upon recurrence to improve outcomes.

Keyword

Focal segmental glomerulosclerosis; Kidney transplantation; Recurrence

Figure

• 

  Fig. 1. Management strategy for recurrent focal segmental glomerulosclerosis (FSGS). KT, kidney transplantation; KF, kidney failure; IS, immunosuppression.

Reference

References

1. Park PG, Kang HG, Park E, Ahn YH, Choi HJ, Han KH, et al. Baseline characteristics of participants enrolled in the KoreaN cohort study for Outcomes in patients With Pediatric Chronic Kidney Disease (KNOW-Ped CKD). Pediatr Nephrol. 2022; 37:3177–87. DOI: 10.1007/s00467-021-05278-3. PMID: 35277754.

2. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012; 27:363–73. DOI: 10.1007/s00467-011-1939-1. PMID: 21713524.

3. Davin JC, Rutjes NW. Nephrotic syndrome in children: from bench to treatment. Int J Nephrol. 2011; 2011:372304. DOI: 10.4061/2011/372304. PMID: 21904676.

4. Alenazi SA. Incidence and pathological patterns of nephrotic syndrome among infants and children: a systematic review. Cureus. 2024; 16:e58331. DOI: 10.7759/cureus.58331. PMID: 38752042.

5. Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, et al. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2005; 20:735–42. DOI: 10.1093/ndt/gfh766. PMID: 15772265.

6. Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant. 2005; 5:2907–12. DOI: 10.1111/j.1600-6143.2005.01112.x. PMID: 16303004.

7. Abbott KC, Sawyers ES, Oliver JD 3rd, Ko CW, Kirk AD, Welch PG, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis. 2001; 37:366–73. DOI: 10.1053/ajkd.2001.21311. PMID: 11157379.

8. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation. 1999; 68:635–41. DOI: 10.1097/00007890-199909150-00007. PMID: 10507481.

9. Ding WY, Koziell A, McCarthy HJ, Bierzynska A, Bhagavatula MK, Dudley JA, et al. Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence. J Am Soc Nephrol. 2014; 25:1342–8. DOI: 10.1681/asn.2013080852. PMID: 24511128.

10. Garrouste C, Canaud G, Buchler M, Rivalan J, Colosio C, Martinez F, et al. Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: clinical outcomes. Transplantation. 2017; 101:649–56. DOI: 10.1097/tp.0000000000001160. PMID: 27043407.

11. Lanaret C, Anglicheau D, Audard V, Buchler M, Caillard S, Couzi L, et al. Rituximab for recurrence of primary focal segmental glomerulosclerosis after kidney transplantation: results of a nationwide study. Am J Transplant. 2021; 21:3021–33. DOI: 10.1111/ajt.16504. PMID: 33512779.

12. Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, et al. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings. Pediatr Nephrol. 2018; 33:1773–80. DOI: 10.1007/s00467-018-3994-3. PMID: 29982878.

13. Subramani V, Venkatasubramanian V, Sethi J, Sekar A, Patil SS, Kenwar DB, et al. Immediate recurrence of genetic focal segmental glomerulosclerosis postkidney transplant. Indian J Transplant. 2024; 18:207–9. DOI: 10.4103/ijot.ijot_128_23.

14. Ferreira da Mata G, Mansur JB, Riguetti MT, Rezende GF, Osmar de Medina Pestana J, Mastroianni Kirsztajn G. A single-center, retrospective study of focal segmental glomerulosclerosis after kidney transplantation: evolutive analysis. Int J Organ Transplant Med. 2021; 12:1–10.

15. Vinai M, Waber P, Seikaly MG. Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review. Pediatr Transplant. 2010; 14:314–25. DOI: 10.1111/j.1399-3046.2009.01261.x. PMID: 20519016.

16. Nehus EJ, Goebel JW, Succop PS, Abraham EC. Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk. Transplantation. 2013; 96:550–4. DOI: 10.1097/tp.0b013e31829c2431. PMID: 23912170.

17. Morello W, Puvinathan S, Puccio G, Ghiggeri GM, Dello Strologo L, Peruzzi L, et al. Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience. J Nephrol. 2020; 33:849–57. DOI: 10.1007/s40620-019-00660-9. PMID: 31617157.

18. Mang J, Hennig L, Liefeldt L, Duerr M, Lehner LJ, Bichmann A, et al. Focal segmental glomerulosclerosis and recurrence in living donor recipients. Res Rep Urol. 2021; 13:495–9. DOI: 10.2147/rru.s308994. PMID: 34285889.

19. Francis A, Trnka P, McTaggart SJ. Long-term outcome of kidney transplantation in recipients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2016; 11:2041–6. DOI: 10.2215/cjn.03060316. PMID: 27797890.

20. Uffing A, Perez-Saez MJ, Mazzali M, Manfro RC, Bauer AC, de Sottomaior Drumond F, et al. Recurrence of FSGS after kidney transplantation in adults. Clin J Am Soc Nephrol. 2020; 15:247–56. PMID: 31974287.

21. Shirai Y, Miura K, Ishizuka K, Ando T, Kanda S, Hashimoto J, et al. A multi-institutional study found a possible role of anti-nephrin antibodies in post-transplant focal segmental glomerulosclerosis recurrence. Kidney Int. 2024; 105:608–17. DOI: 10.1016/j.kint.2023.11.022. PMID: 38110152.

22. Batal I, Watts AJ, Gibier JB, Hamroun A, Top I, Provot F, et al. Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft. Kidney Int. 2024; 106:749–52. DOI: 10.1016/j.kint.2024.07.022. PMID: 39127225.

23. Delville M, Sigdel TK, Wei C, Li J, Hsieh SC, Fornoni A, et al. A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med. 2014; 6:256ra136. DOI: 10.1126/scitranslmed.3008538. PMID: 25273097.

24. Weber LT, Tonshoff B, Grenda R, Bouts A, Topaloglu R, Gulhan B, et al. Clinical practice recommendations for recurrence of focal and segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Pediatr Transplant. 2021; 25:e13955. DOI: 10.1111/petr.13955. PMID: 33378587.

25. Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, et al. Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr Transplant. 2014; 18:29–34. DOI: 10.1111/petr.12185. PMID: 24266922.

26. Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, et al. Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation. 2001; 71:628–33. DOI: 10.1097/00007890-200103150-00008. PMID: 11292291.

27. Belson A, Yorgin PD, Al-Uzri AY, Salvatierra O, Higgins J, Alexander SR. Long-term plasmapheresis and protein A column treatment of recurrent FSGS. Pediatr Nephrol. 2001; 16:985–9. DOI: 10.1007/s004670100008. PMID: 11793085.

28. Canaud G, Dion D, Zuber J, Gubler MC, Sberro R, Thervet E, et al. Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant. 2010; 25:1321–8. DOI: 10.1093/ndt/gfp500. PMID: 19773419.

29. Raina R, Wang J, Sharma A, Chakraborty R. Extracorporeal therapies in the treatment of focal segmental glomerulosclerosis. Blood Purif. 2020; 49:513–23. DOI: 10.1159/000506277. PMID: 32074606.

30. Shah L, Hooper DK, Okamura D, Wallace D, Moodalbail D, Gluck C, et al. LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr Nephrol. 2019; 34:2343–50. DOI: 10.1007/s00467-019-04296-6. PMID: 31250206.

31. Grenda R, Jarmuzek W, Rubik J, Piatosa B, Prokurat S. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome. Eur J Pediatr. 2016; 175:1133–7. DOI: 10.1007/s00431-016-2747-1. PMID: 27364906.

32. Solomon S, Zolotnitskaya A, Del Rio M. Ofatumumab in post-transplantation recurrence of focal segmental glomerulosclerosis in a child. Pediatr Transplant. 2019; 23:e13413. DOI: 10.1111/petr.13413. PMID: 30973669.

33. Seeman T, Dusek J, Vondrak K, Janda J. Ramipril in the treatment of proteinuria in children after renal transplantation. Pediatr Transplant. 2010; 14:283–7. DOI: 10.1111/j.1399-3046.2009.01216.x. PMID: 19686445.

34. Nathanson S, Cochat P, Andre JL, Guyot C, Loirat C, Nivet H, et al. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression. Pediatr Nephrol. 2005; 20:1801–4. DOI: 10.1007/s00467-005-2053-z. PMID: 16228184.

35. Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013; 369:2416–23. PMID: 24206430.

36. Leroy S, Guigonis V, Bruckner D, Emal-Aglae V, Deschenes G, Bensman A, et al. Successful anti-TNFalpha treatment in a child with posttransplant recurrent focal segmental glomerulosclerosis. Am J Transplant. 2009; 9:858–61. DOI: 10.1111/j.1600-6143.2009.02550.x. PMID: 19344472.

37. Mittal T, Dedhia P, Roy-Chaudhury P, Abu Jawdeh BG, Mogilishetty G, Cuffy MC, et al. Complete remission of post-transplantation recurrence of focal segmental glomerulosclerosis with the use of adrenocorticotrophic hormone gel: case report. Transplant Proc. 2015; 47:2219–22. DOI: 10.1016/j.transproceed.2015.07.013. PMID: 26361683.

38. Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, et al. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int. 2012; 25:e62–6. DOI: 10.1111/j.1432-2277.2012.01462.x. PMID: 22409658.

39. Meyer TN, Thaiss F, Stahl RA. Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int. 2007; 20:1066–71. DOI: 10.1111/j.1432-2277.2007.00562.x. PMID: 17887957.